Verastem Oncology
VSTM
#8150
Rank
โ‚ฌ0.16 B
Marketcap
3,75ย โ‚ฌ
Share price
3.69%
Change (1 day)
-36.41%
Change (1 year)

Revenue for Verastem Oncology (VSTM)

Revenue in 2024 (TTM): โ‚ฌ9.32 Million

According to Verastem Oncology 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ9.53 Million. In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of โ‚ฌ2.42 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Verastem Oncology from 2011 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ9.32 M
2023 N/A-100%
2022 โ‚ฌ2.42 M33.5%
2021 โ‚ฌ1.81 M-97.48%
2020 โ‚ฌ71.96 M361.86%
2019 โ‚ฌ15.58 M-33.28%
2018 โ‚ฌ23.35 M
2017 N/A
2016 N/A
2015 N/A
2014 N/A
2013 N/A
2012 N/A
2011 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ9.68 M 1.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ53.04 B 556,320.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ12.12 B 127,028.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ38.37 B 402,427.07%๐Ÿ‡ฌ๐Ÿ‡ง UK